Lanvin Group Holdings Limited (LANV)
NYSE: LANV · IEX Real-Time Price · USD
1.590
+0.020 (1.27%)
At close: Jul 19, 2024, 4:00 PM
1.670
+0.080 (5.03%)
After-hours: Jul 20, 2024, 12:56 PM EDT
Lanvin Group Employees
Lanvin Group Holdings had 2,637 employees as of December 31, 2023. The number of employees decreased by 850 or -24.38% compared to the previous year.
Employees
2,637
Change (1Y)
-850
Growth (1Y)
-24.38%
Revenue / Employee
$179,572
Profits / Employee
-$54,487
Market Cap
230.58M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2,637 | -850 | -24.38% |
| Dec 31, 2022 | 3,487 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Potbelly | 5,000 |
| Sleep Number | 4,131 |
| Rocky Brands | 2,100 |
| Inspired Entertainment | 1,700 |
| Mondee Holdings | 1,226 |
| Clarus | 500 |
| Fitell | 17 |
LANV News
- 24 days ago - LANVIN APPOINTS PETER COPPING ARTISTIC DIRECTOR - PRNewsWire
- 5 weeks ago - Regis Rimbert Named CEO of Wolford AG - PRNewsWire
- 6 weeks ago - ees Europe: Battery Storage – Powerbanks for the Energy Transition - Business Wire
- 7 weeks ago - BESREMi® (Ropeginterferon alfa-2B) Shows Greatest Benefit Among Cytoreductive Therapies in Lowering Symptomatic Burden of Polycythemia Vera (PV): Real-World Analysis Published at ASCO - Business Wire
- 2 months ago - Lanvin Group Shows Resiliency in Sales and On-Track Margin Improvement in 2023 - PRNewsWire
- 3 months ago - Lanvin Group to Report 2023 Full-Year Audited Results on April 30, 2024 - PRNewsWire
- 4 months ago - Analyses Find Patients With Polycythemia Vera (PV) Treated With BESREMi® (ropeginterferon alfa-2b) Had Increased Probability of Achieving Complete Hematologic Response - Business Wire
- 5 months ago - Lanvin Group Resiliency was Key in 2023, Preliminary Revenues Up 1% Year-on-Year - PRNewsWire